Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models.
Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models. Sci Rep. 2019 12 11; 9(1):18882.
View in:
PubMed
subject areas
Animals
Animals
Antineoplastic Agents
Antineoplastic Agents
Cell Line, Tumor
Cell Line, Tumor
Cell Proliferation
Cell Proliferation
DNA Damage
DNA Damage
DNA-Activated Protein Kinase
DNA-Activated Protein Kinase
Doxorubicin
Doxorubicin
Drug Therapy, Combination
Drug Therapy, Combination
Etoposide
Etoposide
Female
Female
Humans
Humans
Mice
Mice
Mice, Nude
Mice, Nude
Ovarian Neoplasms
Ovarian Neoplasms
Polyethylene Glycols
Polyethylene Glycols
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Topoisomerase II Inhibitors
Topoisomerase II Inhibitors
Tumor Burden
Tumor Burden
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Kathleen Moore